Literature DB >> 15271117

Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study.

Sébastien Weill-Engerer1, Sylvie Meaume, Amina Lahlou, François Piette, Olivier Saint-Jean, Annick Sachet, Jean-Yves Beinis, Claude Gallinari, Anne-Sophie Grancher, Jean-Pierre Vincent, Henri Naga, Joel Belmin, Rosella Salvatore, Marie Kazes, Eric Pautas, André Boiffin, Jean-Bernard Piera, Monique Duviquet, David Knafo, Andrée Piau, Dragoslav Miric, Alain Jean, Valérie Bellamy, Olivier Tissandier, Alain-Ferdinand Le Blanche.   

Abstract

OBJECTIVES: To identify independent risk factors of symptomatic deep vein thrombosis (DVT) in geriatric inpatients and to define high-risk patients likely to benefit from preventive treatment.
DESIGN: Hospital-based case-control multicenter study with prospective data collection. SETTINGS: Geriatric university hospitals with long-, intermediate-, and short-term care facilities. PARTICIPANTS: All patients aged 65 and older in 19 geriatric departments were submitted to clinical surveillance over a 16-month period. MEASUREMENTS: Twenty-three potential risk factors of phlebitis were screened for. Comparison using logistic regression of 310 consecutive patients with symptomatic DVT versus 310 randomly selected controls was performed. The risk for symptomatic DVT in geriatrics was then scored from the clinical risk factors identified using multivariate analysis. This score is defined by the sum of the odds ratio (OR) of each risk factor present.
RESULTS: Six factors were identified as independently related to the development of DVT: restriction of mobility (from OR=1.73, limited mobility without immobilization, to OR=5.64, bedridden during <15 days), aged 75 and older (OR=1.5/10 years), history of DVT or pulmonary embolism (OR=3.38), acute heart failure (OR=2.52), chronic edema of the lower limbs (OR=2.51), and paresis or paralysis of a lower limb (OR=2.06). The defined score of 8 or higher corresponded to an 88.7% probability of having symptomatic DVT.
CONCLUSION: Treatments to prevent symptomatic DVT in hospitalized elderly should be evaluated on patients with these factors.

Entities:  

Mesh:

Year:  2004        PMID: 15271117     DOI: 10.1111/j.1532-5415.2004.52359.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  31 in total

1.  Risk factors of acute pulmonary thromboembolism in Japanese patients hospitalized for medical illness: results of a multicenter registry in the Japanese society of pulmonary embolism research.

Authors:  Mashio Nakamura; Masahito Sakuma; Norikazu Yamada; Nobuhiro Tanabe; Norifumi Nakanishi; Yoshiyuki Miyahara; Takayuki Kuriyama; Takeyoshi Kunieda; Kunio Shirato; Tsuneaki Sugimoto; Takeshi Nakano
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  [Thrombosis prophylaxis in geriatric patients].

Authors:  R E Roller; P Feichtinger
Journal:  Z Gerontol Geriatr       Date:  2012-04       Impact factor: 1.281

4.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

Review 5.  Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review.

Authors:  Wei Huang; Frederick A Anderson; Frederick A Spencer; Alexander Gallus; Robert J Goldberg
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

Review 6.  Management of venous thromboembolism in the elderly.

Authors:  Alex C Spyropoulos; Geno Merli
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 7.  [Coagulation management in geriatric surgery].

Authors:  H Eichler
Journal:  Chirurg       Date:  2017-02       Impact factor: 0.955

8.  Favorable coagulation profile with fondaparinux after hip surgery in elderly patients.

Authors:  Zuzana Kudrnová; Jan Kvasnička; Karel Kudrna; Jiří Mazoch; Ivana Malíková; Zuzana Zenáhlíková; Magda Sudrová; Radka Brzežková
Journal:  Int J Hematol       Date:  2009-10-17       Impact factor: 2.490

Review 9.  Target specific oral anticoagulants in the management of thromboembolic disease in the elderly.

Authors:  Surekha Maddula; Jack Ansell
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

Review 10.  Use of anticoagulants in elderly patients: practical recommendations.

Authors:  Helia Robert-Ebadi; Grégoire Le Gal; Marc Righini
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.